Noboru Nakaigawa
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 2%
- Oncology top 5%
- Surgery top 10%
- Co-authors
- Yoshinobu KubotaMasahiro YaoTakeshi KishidaYoji NagashimaBerton ZbarHitoshi IshiguroYasuhide MiyoshiLaura S. Schmidt
- Topics
- Renal cell carcinoma treatment (60 papers)Renal and related cancers (29 papers)Bladder and Urothelial Cancer Treatments (24 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesPoland
In The Last Decade
Noboru Nakaigawa
119 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 1.8k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 734
- Oncology 719
- Surgery 475
Countries citing papers authored by Noboru Nakaigawa
This map shows the geographic impact of Noboru Nakaigawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Nakaigawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Nakaigawa more than expected).
Fields of papers citing papers by Noboru Nakaigawa
This network shows the impact of papers produced by Noboru Nakaigawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Nakaigawa. The network helps show where Noboru Nakaigawa may publish in the future.
Co-authorship network of co-authors of Noboru Nakaigawa
This figure shows the co-authorship network connecting the top 25 collaborators of Noboru Nakaigawa. A scholar is included among the top collaborators of Noboru Nakaigawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noboru Nakaigawa. Noboru Nakaigawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 5 | |
| 7 | 13 | |
| 8 | 10 | |
| 9 | 44 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 10 | |
| 13 | 51 | |
| 14 | 73 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 57 | |
| 18 | 37 | |
| 19 | Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and prostate cancer cells | 1 |
| 20 | 43 |
About Noboru Nakaigawa
Noboru Nakaigawa is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 127 papers that have together received 3.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (60 papers), Renal and related cancers (29 papers) and Bladder and Urothelial Cancer Treatments (24 papers). The work is most often cited by research in Hepatology (457 citations), Cancer Research (734 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Noboru Nakaigawa has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Yoshinobu Kubota, Masahiro Yao, Takeshi Kishida, Yoji Nagashima, Berton Zbar, Hitoshi Ishiguro, Yasuhide Miyoshi, Laura S. Schmidt, Gregor Weirich and Hiroji Uemura. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.